Showing results (11-20 of 312) with videos related to
Sort By:
Pageof 32
Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)|December 25, 2007
[Refractory schizophrenia]Helio Elkis, Herbert Y MeltzerBehavioural Brain Research|August 19, 2008
Does stimulation of 5-HT(1A) receptors improve cognition in schizophrenia?Herbert Y Meltzer, Tomiki SumiyoshiJournal of Comparative Effectiveness Research|November 19, 2013
Tying comparative effectiveness information to decision-making and the future of comparative effectiveness research designs: the case for antipsychotic drugsAnirban Basu, Herbert Y MeltzerThe International Journal of Neuropsychopharmacology|September 17, 2003
Antipsychotic drugs in bipolar disorderAygun Ertugrul, Herbert Y MeltzerProgress in Brain Research|September 6, 2008
In vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic systemsHerbert Y Meltzer, Mei HuangFocus (American Psychiatric Publishing)|September 6, 2021
Contrasting Typical and Atypical Antipsychotic DrugsHerbert Y Meltzer, Erick GadaletaSchizophrenia Research|June 7, 2006
Differential trends in prevalence of diabetes and unrelated general medical illness for schizophrenia patients before and after the atypical antipsychotic eraAnirban Basu, Herbert Y MeltzerSchizophrenia Research|September 17, 2014
A genetic locus in 7p12.2 associated with treatment resistant schizophreniaJiang Li, Herbert Y MeltzerBiological Psychiatry|March 3, 2009
Dopamine D2 receptor levels in striatum, thalamus, substantia nigra, limbic regions, and cortex in schizophrenic subjectsRobert M Kessler, Neil D Woodward, Patrizia Riccardi, et al.CNS Spectrums|July 4, 2006
Interpreting the efficacy findings in the CATIE study: what clinicians should knowHerbert Y Meltzer, William V BoboPageof 32